Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1
Gogev, S.; de Fays, K.; Jaspar-Versali, Marie-Franceet al.
chitosan; bovine herpesvirus 1; glycoprotein D; recombinant human adenovirus type 5
Abstract :
[en] The ability of two soluble formulations, namely chitosan and glycol chitosan, when used as an intranasal adjuvant, to improve the immunogenicity of an intranasal human adenovirus type 5 replication defective expressing bovine herpesvirus 1 (BoHV-1) glycoprotein D based vaccine, was investigated in cattle. Their adjuvant effects on immune response by increasing clinical and especially virological protection against an intranasal BoHV-1 challenge were then evaluated. The best virological protection was obtained in calves immunized with the vaccine vector adjuvanted with glycol chitosan which decreased the challenge BoHV-1 virus excretion titres by 0.5-1.5 log when compared to those obtained in calves immunized with the vaccine vector alone or adjuvanted with chitosan. A slight difference in clinical scores was observed in calves immunized with the adjuvanted vaccine vector compared to calves immunized with the vaccine vector alone. The obtained data suggest that the tested soluble formulation of glycol chitosan has promising potential use as an intranasal adjuvant for recombinant viral vector vaccines in cattle. (C) 2003 Elsevier Ltd. All rights reserved.
Disciplines :
Immunology & infectious disease Laboratory medicine & medical technology Veterinary medicine & animal health
Author, co-author :
Gogev, S.
de Fays, K.
Jaspar-Versali, Marie-France ; Université de Liège - ULiège > Département des sciences de la vie > Biologie moléculaire et biotechnologie végétales
Gautier, S.
Thiry, Etienne ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires > Virologie, épidémiologie et pathologie des maladies virales
Language :
English
Title :
Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1
Soane R.J., Hinchcliffe M., Davis S.S., Illum L. Clearance characteristics of chitosan based formulations in the sheep nasal cavity. Int. J. Pharm. 217:2001;183-191
Illum L. Transport of drugs from the nasal cavity to the central nervous system. Eur. J. Pharm. Sci. 11:2000;1-18
Tamura S., Samegai Y., Kurata H., Nagamine T., Aizawa C., Kurata T. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine. 6:1988;409-413
Tamura S., Asanuma H., Tomita T., Komase K., Kawahara K., Danbara H., et al. Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine. Vaccine. 12:1994;1083-1089
Jabbal-Gill I., Fisher A.N., Rappuoli R., Davis S.S., Illum L. Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice. Vaccine. 16:1998;2039-2046
Bacon A., Makin J., Sizer P.J., Jabbal-Gill I., Hinchcliffe M., Illum L., et al. Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens. Infect. Immun. 68:2000;5764-5770
McCluskie M.J., Weeratna R.D., Davis H.L. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution. Mol. Med. 6:2000;867-877
Gogev S., Vanderheijden N., Lemaire M., Schynts F., D'Offay J., Deprez I., et al. Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD. Vaccine. 20:2002;1451-1465
Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15:1998;1326-1331
Aspden T.J., Illum L., Skaugrud Ø. Chitosan as a nasal delivery system: evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models. Eur. J. Pharm. Sci. 4:1996;23-31
Schipper N.G., Olsson S., Hoogstraate J.A., deBoer A.G., Varum K.M., Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. Pharm. Res. 14:1997;923-929
Dodane V., Khan A.M., Merwin J.R. Effect of chitosan on epithelial permeability and structure. Int. J. Pharm. 18:1999;221-232
Artursson P., Lindmark T., Davis S.S., Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 11:1994;1358-1361
Illum L., Farraj N.F., Davis S.S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11:1994;1186-1189
Fernandez-Urrusuno R., Calvo P., Remunan-Lopez C., Vila-Jato J.L., Alonso M.J. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res. 16:1999;1576-1581
Tengamnuay P., Sahamethapat A., Sailasuta A., Mitra A.K. Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts. Int. J. Pharm. 197:2000;53-67
McNeela E.A., O'Connor D., Jabbal-Gill I., Illum L., Davis S.S., Pizza M., et al. A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery. Vaccine. 19:2000;1188-1198
Wyler R, Engels M, Schwyzer M. Infectious bovine rhinotracheitis/ vulvovaginitis (BOHV-1). In: Wittmann G, editor. Herpesvirus diseases of cattle, horses and pigs: developments in veterinary virology. Boston: Kluwer Academic Publishers; 1989. p. 1-72.
van Oirschot J.T., Kaashoek M.J., Rijsewijk F.A. Advances in the development and evaluation of bovine herpesvirus 1 vaccines. Vet. Microbiol. 53:1996;43-54
Zakhartchouk A., Pyne C., Mutwiri G.K., Papp Z., Baca-Estrada M.A., Griebel P., et al. Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1. J. Gen. Virol. 80:1999;1263-1269
Reddy P.S., Idamakanti N., Pyne C., Zakhartchouk A.N., Godson D.L., Papp Z., et al. The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle. Vet. Immunol. Immunopathol. 76:2000;257-268
Kaashoek M.J., Straver P.H., Van Rooij E.M., Quak J., Van Oirschot J.T. Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1 strains: clinical and virological aspects. Vet. Rec. 139:1996;416-421
Lemaire M., Weynants V., Godfroid J., Schynts F., Meyer G., Letesson J.-J., et al. Effects of bovine herpesvirus type 1 infection in calves with maternal antibodies on immune response and viral latency. J. Clin. Microbiol. 38:2000;1885-1894
Lemaire M., Schynts F., Meyer G., Thiry E. Antibody response to glycoprotein E after bovine herpesvirus type 1 infection in passively immunized, glycoprotein E-negative calves. Vet. Rec. 144:1999;172-176
Soane R.J., Hinchcliffe M., Davis S.S., Illum L. Clearance characteristics of chitosan based formulations in the sheep nasal cavity. Int. J. Pharm. 217:2001;183-191
Tabata Y., Inoue Y., Ikada Y. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. Vaccine. 14:1996;1677-1685
Van Der Lubben I.M., Konings F.A., Borchard G., Verhoef J.C., Junginger H.E. In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry. J. Drug. Target. 9:2001;39-47
Kotzé A.F., Luessen H.L., de Leeuw B.J., de Boer A.G., Verhoef J.C., Junginger H.E. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J. Control Release. 51:1998;35-46
Thanou M.M., Kotze A.F., Scharringhausen T., Luessen H.L., de Boer A.G., Verhoef J.C., et al. Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers. J. Control Release. 64:2000;15-25
Thanou M., Verhoef J.C., Junginger H.E. Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug. Deliv. Rev. 52:2001;117-126
Muzzarelli R.A., Tanfani F., Emmanueli M., Mariotti S. N-(Carboxymethylidene)-chitosans and N-(caboxymethyl)-chitosans: novel chelating polyampholytes obtained from chitosan glyoxylate. Carbohydr. Res. 107:1982;199-214
